[
    [
        {
            "time": "2019-10-29",
            "original_text": "Lilly Confirms Date and Conference Call for Third-Quarter 2019 Financial Results Announcement",
            "features": {
                "keywords": [
                    "Lilly",
                    "Third-Quarter",
                    "Financial Results",
                    "Conference Call"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly Confirms Date and Conference Call for Third-Quarter 2019 Financial Results Announcement",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-11-05",
            "original_text": "Agios' Tibsovo Improves Survival in Cholangiocarcinoma Study",
            "features": {
                "keywords": [
                    "Agios",
                    "Tibsovo",
                    "Improves Survival",
                    "Cholangiocarcinoma"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Agios' Tibsovo Improves Survival in Cholangiocarcinoma Study",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-04",
            "original_text": "Novartis (NVS) Announces Data on Asthma Drugs & Kisqali",
            "features": {
                "keywords": [
                    "Novartis",
                    "Asthma Drugs",
                    "Kisqali",
                    "Data Announcement"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novartis (NVS) Announces Data on Asthma Drugs & Kisqali",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]